Abstract
The present invention relates to an ultrasensitive assay platform for the detection of nucleic acids such as microRNAs (miRNAs), which are important biomarker for diseases including cancer. The platform allows high throughput detection of multiple nucleic acid sequences miRNAs on the single-molecule level using fluorescence labeling, molecular barcoding, and flow based detection and multiparametric data analysis.
| Original language | English (US) |
|---|---|
| U.S. patent number | 11618919 |
| Filing date | 5/22/20 |
| State | Published - Apr 4 2023 |